mounjaro glp-1 vs. Ozempic: What's the Difference GLP-1 medications like Ozempic, Wegovy

David LaMond, Medical Director, Blue Sky MD I cant tell you how many times patients walk into my office with questions about GLP-1 medications

1 model

In clinical trials of SGLT2 inhibitors in type 2 diabetes, discontinuation rates among those receiving active treatment have been less variable, ranging from 21% during a median follow-up time of 50 months in the DECLARE-TIMI 58 trial of dapagliflozin to 29% during a mean follow-up time of 43 months in the CANVAS trial of canagliflozin [14,15,16,17,18]

[DOI] [PMC free article] [PubMed] [Google Scholar] 93.Busetto L., Dicker D., Fruhbeck G., Halford J.C.G., Sbraccia P., Yumuk V., Goossens G.H

Eur J Pharmacol (2021) 903:174145

M.WebsterS